Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-β1 and interleukin-6 in the development of in situ tumor immunity
- 1 November 2005
- journal article
- Published by Elsevier in Immunobiology
- Vol. 210 (9) , 661-671
- https://doi.org/10.1016/j.imbio.2005.07.004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Transforming growth factor-β induces apoptosis in antigen-specific CD4+ T cells prepared for adoptive immunotherapyImmunology Letters, 2003
- Regulating the RegulatorsScience, 2003
- Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic CellsScience, 2003
- Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-β1 is mediated by caspase-dependent and -independent processesLeukemia, 2002
- How much longer will tumour cells fool the immune system?Immunology Today, 2000
- Transforming Growth Factor-βs: A Multifunctional Cytokine FamilyHormone Research, 1996
- The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells.The Journal of Experimental Medicine, 1994
- Transforming growth factor beta: the good, the bad, and the ugly.The Journal of Experimental Medicine, 1994
- Role of transforming growth factor β in testicular immunosuppressionJournal of Reproductive Immunology, 1993
- Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cellsCancer Immunology, Immunotherapy, 1988